IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo

Gut

Volumn 66, Issue 5, 2016, Pages 823-838

  Scheibe, Kristina ^a   Backert, Ingo ^a   Wirtz, Stefan ^a   Hueber, Axel ^a   Schett, Georg ^a   Vieth, Michael ^b   Probst, Hans Christian ^c   Bopp, Tobias ^c   Neurath, Markus F ^a   Neufert, Clemens ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; CD14 ANTIGEN; CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 36 ALPHA; INTERLEUKIN 36 GAMMA; INTERLEUKIN 36 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG; DEXTRAN SULFATE; IL36A PROTEIN, HUMAN; IL36G PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN-36 RECEPTOR, HUMAN; INTERLEUKIN-36 RECEPTOR, MOUSE; LIGAND; MYD88 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CROHN DISEASE; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE PREDISPOSITION; EXPERIMENTAL COLITIS; FIBROBLAST; GENE EXPRESSION; HEALING; HUMAN; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MOUSE; MUCOSAL HEALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA SEQUENCE; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WOUND HEALING; ANIMAL; BIOSYNTHESIS; CELL NUCLEUS; CHEMICALLY INDUCED; COLITIS; CYTOPLASM; EPITHELIUM CELL; GENETICS; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CALGRANULIN B; CELL NUCLEUS; CELL PROLIFERATION; CHEMOKINES; COLITIS; CYTOKINES; CYTOPLASM; DEXTRAN SULFATE; EPITHELIAL CELLS; FIBROBLASTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1; INTERLEUKIN-6; INTESTINAL MUCOSA; LIGANDS; LIPOCALIN-2; MACROPHAGES; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84956693215     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-310374     Document Type: Article

References (48)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
2. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011;365:1713-25.
3. MacDonald TT, Monteleone I, Fantini MC, et al. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011;140:1768-75.
4. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014;14:329-42.
5. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1756-67.
6. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-24.
7. Atreya R, Zimmer M, Bartsch B, et al. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14(+) macrophages. Gastroenterology 2011;141:2026-38.
8. Salcedo R, Worschech A, Cardone M, et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 2010;207:1625-36.
9. Oboki K, Ohno T, Kajiwara N, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 2010;107:18581-6.
10. Bersudsky M, Luski L, Fishman D, et al. Non-redundant properties of IL-1alpha and IL-1beta during acute colon inflammation in mice. Gut 2014;63:598-609.
11. Pastorelli L, Garg RR, Hoang SB, et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci USA 2010;107:8017-22.
12. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity 2013;39:1003-18.
13. Towne JE, Garka KE, Renshaw BR, et al. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 2004;279:13677-88.
14. Tortola L, Rosenwald E, Abel B, et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 2012;122:3965-76.
15. Vigne S, Palmer G, Lamacchia C, et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011;118:5813-23.
16. Towne JE, Renshaw BR, Douangpanya J, et al. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity. J Biol Chem 2011;286:42594-602.
17. Blumberg H, Dinh H, Trueblood ES, et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 2007;204:2603-14.
18. Ramadas RA, Ewart SL, Iwakura Y, et al. IL-36alpha exerts pro-inflammatory effects in the lungs of mice. PLoS ONE 2012;7:e45784.
19. Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011;365:620-8.
20. van de Veerdonk FL, Stoeckman AK, Wu G, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci USA 2012;109:3001-5.
21. Derer A, Groetsch B, Harre U, et al. Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis. PLoS ONE 2014;9:e101954.
22. Mifflin RC, Pinchuk IV, Saada JI, et al. Intestinal myofibroblasts: targets for stem cell therapy. Am J Physiol Gastrointest Liver Physiol 2011;300:G684-96.
23. Neurath MF, Wittkopf N, Wlodarski A, et al. Assessment of tumor development and wound healing using endoscopic techniques in mice. Gastroenterology 2010;139:1837-43.e1.
24. Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012;61:1619-35.
25. Cohen I, Rider P, Carmi Y, et al. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci USA 2010;107:2574-9.
26. Carriere V, Roussel L, Ortega N, et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007;104:282-7.
27. Lefrançais E, Roga S, Gautier V, et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 2012;109:1673-8.
28. Afonina IS, Tynan GA, Logue SE, et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alpha. Mol Cell 2011;44:265-78.
29. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007;2:541-6.
30. Rieder F, Fiocchi C. Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 2009;6:228-35.
31. Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science 2009;324:1666-9.
32. Neufert C, Becker C, Türeci Ö, et al. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. J Clin Invest 2013;123:1428-43.
33. Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009;206:1465-72.
34. Xu Y, Hunt NH, Bao S. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res 2008;18:1220-9.
35. Egea L, McAllister CS, Lakhdari O, et al. GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa. J Immunol 2013;190:1702-13.
36. Choi JS, Kim KH, Lau LF. The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol 2015;8:1285-96.
37. Gout T, Ostör AJ, Nisar MK. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review. Clin Rheumatol 2011;30:1471-4.
38. Zhang R, Ito S, Nishio N, et al. Up-regulation of Gr1+CD11b+ population in spleen of dextran sulfate sodium administered mice works to repair colitis. Inflamm Allergy Drug Targets 2011;10:39-46.
39. Zindl CL, Lai JF, Lee YK, et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA 2013;110:12768-73.
40. Shea-Donohue T, Thomas K, Cody MJ, et al. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun 2008;14:117-24.
41. Cowland JB, Sorensen OE, Sehested M, et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003;171:6630-9.
42. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432:917-21.
43. Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006;103:1834-9.
44. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998;9:143-50.
45. Becker C, Fantini MC, Wirtz S, et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 2005;54: 950-4.
46. Backert I, Koralov SB, Wirtz S, et al. STAT3 Activation in Th17 and Th22 Cells Controls IL-22-Mediated Epithelial Host Defense during Infectious Colitis. J Immunol 2014;193:3779-91.
47. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262-5.
48. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.